Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: * Body mass index of 18.0 to 32.0 kg/m2, inclusive, and weight ≥ 50 kg, at screening * Estimated glomerular filtration rate (eGFR) \> 80 mL/min/1.732 calculated with the Chronic Kidney Disease Epidemiology Collaboration formula Exclusion Criteria: * Any significant acute or chronic medical illness * Current or recent (within 3 months of study drug administration) disease of the gut that, in the opinion of the Investigator or Medical Monitor, could impact upon the absorption of study drug * Acute diarrhea, or constipation within 3 weeks prior to randomization * Any major surgery within 4 weeks of randomization Other protocol defined inclusion/exclusion criteria could apply